Anticholinergic Burden Calculator
This tool calculates your Anticholinergic Cognitive Burden (ACB) score based on the University of Washington scale. Total score ≥3 indicates high risk of dangerous sedation.
Use the calculator above to assess your risk. Consult your doctor if your score is 3 or higher.
Combining antihistamines with other sedating drugs can be dangerous-sometimes life-threatening. You might think taking Benadryl for allergies or sleep is harmless, especially since it’s available over the counter. But when mixed with painkillers, anxiety meds, or even alcohol, the effects can add up fast. The result? Extreme drowsiness, confusion, slowed breathing, or worse. This isn’t rare. Every year, over 300,000 emergency room visits in the U.S. are tied to these kinds of drug clashes, and antihistamines are involved in nearly 15% of them.
Why Some Antihistamines Are Riskier Than Others
Not all antihistamines are the same. There are two main types: first-generation and second-generation. The difference isn’t just about how well they stop sneezing-it’s about what they do to your brain.First-generation antihistamines like diphenhydramine (Benadryl), hydroxyzine (Vistaril), and promethazine (Phenergan) cross the blood-brain barrier easily. They block histamine receptors, yes-but they also mess with acetylcholine, a key brain chemical. That’s why they cause drowsiness, dry mouth, blurred vision, and memory issues. On the Anticholinergic Cognitive Burden (ACB) scale, diphenhydramine scores a 3-meaning it’s high risk. This isn’t just a side effect; it’s a pharmacological punch to the central nervous system.
Second-generation antihistamines like loratadine (Claritin), cetirizine (Zyrtec), and fexofenadine (Allegra) were designed differently. They’re built to stay out of the brain. Thanks to special transporters that pump them back out of brain tissue, they barely cause drowsiness. Their ACB score? Usually 0 or 1. That’s why 97% of users report no sleepiness with loratadine, compared to 68% with diphenhydramine.
Which Medications Should You Avoid Mixing With Antihistamines?
The biggest danger comes from combining antihistamines with other drugs that slow down your nervous system. These include:- Benzodiazepines like lorazepam (Ativan) or alprazolam (Xanax)
- Opioid painkillers like oxycodone, hydrocodone, or codeine
- Sleep aids like zolpidem (Ambien) or eszopiclone (Lunesta)
- Alcohol
- Some antidepressants, especially tricyclics like amitriptyline
- Muscle relaxants like cyclobenzaprine (Flexeril)
Here’s what happens when you mix them. A 2013 study showed that diphenhydramine increased the sedative effect of lorazepam by 37% in objective tests-and users felt 42% more drowsy. When opioids and first-gen antihistamines are taken together, the risk of dangerous breathing problems jumps from 1.5% to 8.7%. That’s nearly six times higher.
Even more alarming: people over 65 are at highest risk. Their bodies clear these drugs 50-70% slower. A single 25mg dose of diphenhydramine can linger in an older adult’s system for 12 hours or more. Combine that with a blood pressure med or a bladder control drug (both often anticholinergic), and the risk of delirium spikes by 54%. That’s not just groggy-it’s confusion, hallucinations, falls, and hospitalization.
What About Cimetidine? A Hidden Culprit
Most people don’t realize that cimetidine (Tagamet), an H2 blocker used for heartburn, can make antihistamine interactions worse. It doesn’t cause sedation itself, but it blocks liver enzymes (CYP1A2, CYP2D6, CYP3A4) that break down many drugs. When you take cimetidine with diphenhydramine, the antihistamine builds up in your blood. Levels can rise by 40-70%. That means even a normal dose becomes toxic. This interaction is often missed because cimetidine is sold as an OTC acid reducer-and people assume it’s harmless.
Real Stories, Real Consequences
Reddit threads are full of warnings. One user wrote: “Took Benadryl for allergies, then had a glass of wine. Blacked out. Woke up in the ER with oxygen on my face.” Another said: “I took Xanax and Benadryl to sleep. Couldn’t breathe. My husband called 911.”GoodRx users gave diphenhydramine a 1.8 out of 5 stars for safety, with 63% of negative reviews citing “dangerous drowsiness with other meds.” WebMD reports that 41% of patients who took diphenhydramine with opioids had severe dizziness requiring medical care. In contrast, Allegra (fexofenadine) holds a 4.3-star rating on Amazon with over 18,000 reviews-most praising “no drowsiness even with my anxiety meds.”
Who’s Most at Risk-and What to Do
The people most in danger aren’t just the elderly. Anyone taking three or more medications with anticholinergic effects is at risk. The average Medicare patient takes nearly eight prescriptions. Add OTC sleep aids, allergy pills, and heartburn meds, and you’ve got a perfect storm.Here’s what you can do:
- Check your meds-even the OTC ones. Look for diphenhydramine, doxylamine, hydroxyzine, promethazine, or cimetidine on labels.
- Switch to second-gen-if you’re using Benadryl for allergies or sleep, try loratadine or fexofenadine instead. They work just as well for allergies without the brain fog.
- Use the ACB scale-the University of Washington has a free online calculator. Add up the scores of all your meds. If the total is 3 or higher, talk to your doctor.
- Ask about alternatives-for sleep, melatonin or cognitive behavioral therapy are safer than diphenhydramine. For motion sickness, dimenhydrinate is still an option, but use it only as needed.
Doctors aren’t always aware of the risk. A 2022 study found that 58% of primary care physicians missed dangerous combinations during simulated patient visits. Don’t wait for them to catch it-know your own meds.
What’s Changing in 2026?
The tide is turning. Since 2018, sales of first-generation antihistamines have dropped 12.7% each year. In 2023, second-gen antihistamines made up 83% of the U.S. OTC market. The FDA now requires bold warnings on diphenhydramine packaging: “May cause severe drowsiness when combined with alcohol, opioids, or sleep medications.”Pharmaceutical companies are developing third-generation antihistamines like levocetirizine (Xyzal) and bilastine (Bilaxten), which are even more selective and show no interaction with benzodiazepines-even at high doses. Insurance systems like Kaiser Permanente now have automated alerts that cut antihistamine-related ER visits by 34%.
By 2028, first-gen antihistamines are expected to hold just 22% of the market-down from 37% today. Their future will likely be limited to short-term, specific uses: motion sickness, nighttime nausea, or palliative care under close supervision.
Written by Mallory Blackburn
View all posts by: Mallory Blackburn